tiprankstipranks
Trending News
More News >
Travere Therapeutics (TVTX)
NASDAQ:TVTX
Advertisement

Travere Therapeutics (TVTX) Revenue

Compare
510 Followers

Travere Therapeutics Revenue

Travere Therapeutics had a revenue of 114.45M in the quarter ending Jun 30, 2025, with 40.03%. This bring the company's revenue in the last twelve months to 333.87M, Decreased 22.06%. In the fiscal year ending Dec 31, 2024, Travere Therapeutics had annual revenue of 233.18M with 60.55% growth.
Revenue (ttm)
333.87M
Revenue Growth
87.94%
P/S Ratio
6.85
Revenue/Employee
$605,649
Employees
385
Market Cap
$1.60B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
233.18M87.94M+60.55%
Dec 31, 2023
145.24M-66.78M-31.50%
Dec 31, 2022
212.02M-15.47M-6.80%
Dec 31, 2021
227.49M29.17M+14.71%
Dec 31, 2020
198.32M22.98M+13.11%
Dec 31, 2019
175.34M11.09M+6.75%
Dec 31, 2018
164.25M9.31M+6.01%
Dec 31, 2017
154.94M21.35M+15.98%
Dec 31, 2016
133.59M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis